Biologics of Lumbar Interbody Fusion

Gurmit Singh, Wellington K Hsu*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Lumbar interbody spine fusion is increasingly utilized for treatment of a variety of spinal pathologies. The utilization of biologics in this space has gained significant interest from both—a research and clinical perspective. Historically, iliac crest bone graft has been the gold standard for lumbar interbody spine fusion, however, to avoid donor site morbidity, other options for bone graft substitutes are now commercially available. These include allograft, demineralized bone matrix, ceramics, and recombinant growth factors. More data is needed to assess clinical efficacy of mesenchymal stem cells, platelet rich plasma and peptides.

Original languageEnglish (US)
Pages (from-to)194-202
Number of pages9
JournalSeminars in Spine Surgery
Volume30
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Biological Products
Spine
Transplants
Bone Substitutes
Bone Matrix
Platelet-Rich Plasma
Ceramics
Mesenchymal Stromal Cells
Allografts
Intercellular Signaling Peptides and Proteins
Pathology
Morbidity
Bone and Bones
Peptides
Research

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Singh, Gurmit ; Hsu, Wellington K. / Biologics of Lumbar Interbody Fusion. In: Seminars in Spine Surgery. 2018 ; Vol. 30, No. 4. pp. 194-202.
@article{b8d42063543a489497d246a158f0cdec,
title = "Biologics of Lumbar Interbody Fusion",
abstract = "Lumbar interbody spine fusion is increasingly utilized for treatment of a variety of spinal pathologies. The utilization of biologics in this space has gained significant interest from both—a research and clinical perspective. Historically, iliac crest bone graft has been the gold standard for lumbar interbody spine fusion, however, to avoid donor site morbidity, other options for bone graft substitutes are now commercially available. These include allograft, demineralized bone matrix, ceramics, and recombinant growth factors. More data is needed to assess clinical efficacy of mesenchymal stem cells, platelet rich plasma and peptides.",
author = "Gurmit Singh and Hsu, {Wellington K}",
year = "2018",
month = "12",
day = "1",
doi = "10.1053/j.semss.2018.07.019",
language = "English (US)",
volume = "30",
pages = "194--202",
journal = "Seminars in Spine Surgery",
issn = "1040-7383",
publisher = "W.B. Saunders Ltd",
number = "4",

}

Biologics of Lumbar Interbody Fusion. / Singh, Gurmit; Hsu, Wellington K.

In: Seminars in Spine Surgery, Vol. 30, No. 4, 01.12.2018, p. 194-202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biologics of Lumbar Interbody Fusion

AU - Singh, Gurmit

AU - Hsu, Wellington K

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Lumbar interbody spine fusion is increasingly utilized for treatment of a variety of spinal pathologies. The utilization of biologics in this space has gained significant interest from both—a research and clinical perspective. Historically, iliac crest bone graft has been the gold standard for lumbar interbody spine fusion, however, to avoid donor site morbidity, other options for bone graft substitutes are now commercially available. These include allograft, demineralized bone matrix, ceramics, and recombinant growth factors. More data is needed to assess clinical efficacy of mesenchymal stem cells, platelet rich plasma and peptides.

AB - Lumbar interbody spine fusion is increasingly utilized for treatment of a variety of spinal pathologies. The utilization of biologics in this space has gained significant interest from both—a research and clinical perspective. Historically, iliac crest bone graft has been the gold standard for lumbar interbody spine fusion, however, to avoid donor site morbidity, other options for bone graft substitutes are now commercially available. These include allograft, demineralized bone matrix, ceramics, and recombinant growth factors. More data is needed to assess clinical efficacy of mesenchymal stem cells, platelet rich plasma and peptides.

UR - http://www.scopus.com/inward/record.url?scp=85052233597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052233597&partnerID=8YFLogxK

U2 - 10.1053/j.semss.2018.07.019

DO - 10.1053/j.semss.2018.07.019

M3 - Article

AN - SCOPUS:85052233597

VL - 30

SP - 194

EP - 202

JO - Seminars in Spine Surgery

JF - Seminars in Spine Surgery

SN - 1040-7383

IS - 4

ER -